Delivery Order SPE2DB20D1100-SPE2DB25FD9J6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,160.01 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a $13,620.53 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 11, 2025. This non-set-aside contract was competitively awarded on a firm fixed-price basis and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $35,031.63 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat autoimmune conditions...
- The Defense Logistics Agency awarded a delivery order valued at $12,535.30 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract was awarded on August 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used to treat autoimmune conditions including rheumatoid arthritis, and the...
- The Defense Logistics Agency awarded a delivery order valued at $38,403.45 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitive, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,537.97 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $37,508.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitively awarded contract, which carries no set-aside designation, was finalized on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant commonly prescribed for rheumatoid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $28,464.40 to supply Enbrel 50 mg/mL SureClick prefilled syringes. This firm fixed-price delivery order, which was not set-aside and awarded on July 30, 2025, will be completed by July 31, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. Enbrel is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,265.30 for Enbrel 50 mg/mL SureClick auto-injectors on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9J6Delivery Order
The Defense Logistics Agency awarded a $18,626.31 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick prefilled auto-injectors, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used primarily for treating rheumatoid arthritis and other autoimmune conditions, making this procurement consistent with military healthcare supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which has a total potential value of $999,999,999.00 and runs through December 2026. This prime contract vehicle provides global pharmaceutical support for military healthcare programs worldwide, enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's successful track record of competitively awarded contracts across multiple therapeutic domains demonstrates its capability to fulfill complex federal medical procurement needs efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 8/7/25 |